Sangwon Lee

Sangwon Lee

Auto-generated profile, based on publicly available information

Sangwon Lee

Department of Pharmacology, Yale School of Medicine, New Haven, CT 06520

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2018 in Nature
Verified
Journal Article
Closed access
PDF file
SLSangwon Lee
Sangwon Lee
JCJungyuen Choi
Jungyuen Choi
JMJyotidarsini Mohanty
Jyotidarsini Mohanty
LSLeiliane P. Sousa
Leiliane P. Sousa
FTFrancisco Tome
Francisco Tome
JSJoseph Schlessinger
Joseph Schlessinger

28 April 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
RPRachel J. Perry
Rachel J. Perry
SLSangwon Lee
Sangwon Lee
LMLie Ma
Lie Ma
DZDongyan Zhang
Dongyan Zhang
JSJoseph Schlessinger
Joseph Schlessinger
GSGerald I. Shulman
Gerald I. Shulman
Fibroblast growth factor-1 (FGF1) and FGF19 have been shown to improve glucose metabolism in diabetic rodents, but how this occurs is unknown. Here to investigate the mechanism of action of these growth factors, we perform intracerebroventricular (ICV) injections of recombinant FGF1 or FGF19 in an awake rat model of type 1 diabetes (T1D) and measure rates of whole-body lipolysis, hepatic acetyl CoA content, pyruvate carboxylase activity and hepatic glucose production. We show that ICV injection of FGF19 or FGF1 leads to a ∼60% reduction in hepatic glucose production, hepatic acetyl CoA content and whole-body lipolysis, which results from decreases in plasma ACTH and corticosterone concentrations. These effects are abrogated by an intra-arterial infusion of corticosterone. Taken together these studies identify suppression of the HPA axis and ensuing reductions in hepatic acetyl CoA content as a common mechanism responsible for mediating the acute, insulin-independent, glucose-lowering effects of FGF1 and FGF19 in rodents with poorly controlled T1D.

25 June 2003 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
MMMichael F. Mesleh
Michael F. Mesleh
SLSangwon Lee
Sangwon Lee
GVGianluigi Veglia
Gianluigi Veglia
DTDavid S. Thiriot
David S. Thiriot
FMFrancesca M. Marassi
Francesca M. Marassi
SOStanley Opella
Stanley Opella

1 March 2006 in Journal of Structural and Functional Genomics
Verified
Journal Article
Closed access
PDF file
RPRichard C. Page
Richard C. Page
JMJacob D. Moore
Jacob D. Moore
HNHau B. Nguyen
Hau B. Nguyen
MSMukesh Sharma
Mukesh Sharma
RCRose Chase
Rose Chase
TCTimothy Cross
Timothy Cross

17 July 2011 in Nature
Verified
Journal Article
Open access
PDF file
JHJian Hu
Jian Hu
YXYi Xue
Yi Xue
SLSangwon Lee
Sangwon Lee
YHYa Ha
Ya Ha
The GXGD family of intramembrane proteases includes presenilin, which is mutated in familial Alzheimer's disease, and type 4 prepilin peptidases, which are virulence factors for many pathogenic bacteria. The first crystal structure of a GXGD membrane protease has now been determined. The structure of the FlaK preflagellin peptidase from Methanococcus maripaludis reveals fundamental differences between the GXGD membrane aspartyl protease and its soluble counterparts such as pepsin. Comparison with models of presenilin derived from biochemical analysis suggests that the structure of its active site is similar to that of archaeal FlaK. This structural knowledge will facilitate rational design of inhibitors that target this family of proteases. The GXGD proteases are polytopic membrane proteins with catalytic activities against membrane-spanning substrates that require a pair of aspartyl residues1,2,3,4. Representative members of the family include preflagellin peptidase, type 4 prepilin peptidase, presenilin and signal peptide peptidase. Many GXGD proteases are important in medicine. For example, type 4 prepilin peptidase may contribute to bacterial pathogenesis5,6,7, and mutations in presenilin are associated with Alzheimer’s disease8,9,10. As yet, there is no atomic-resolution structure in this protease family. Here we report the crystal structure of FlaK, a preflagellin peptidase from Methanococcus maripaludis, solved at 3.6 Å resolution. The structure contains six transmembrane helices. The GXGD motif and a short transmembrane helix, helix 4, are positioned at the centre, surrounded by other transmembrane helices. The crystal structure indicates that the protease must undergo conformational changes to bring the GXGD motif and a second essential aspartyl residue from transmembrane helix 1 into close proximity for catalysis. A comparison of the crystal structure with models of presenilin derived from biochemical analysis reveals three common transmembrane segments that are similarly arranged around the active site. This observation reinforces the idea that the prokaryotic and human proteases are evolutionarily related11,12. The crystal structure presented here provides a framework for understanding the mechanism of the GXGD proteases, and may facilitate the rational design of inhibitors that target specific members of the family.

4 February 2004 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GKGerd G. Kochendoerfer
Gerd G. Kochendoerfer
DJDavid H. Jones
David H. Jones
SLSangwon Lee
Sangwon Lee
MOMyrta Oblatt-Montal
Myrta Oblatt-Montal
SOStanley J. Opella
Stanley J. Opella
MMMauricio Montal
Mauricio Montal